课题基金 / 基金详情

Adaptive Artificial Receptors for Biomimetic Functions

Adaptive Artificial Receptors for Biomimetic Functions
仿生功能的自适应人工受体
批准号:
MR/S035486/2
负责人:
Sarah Pike
金额:
$68.85万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

Sarah Pike的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Over the past few decades, chemists have developed very efficient methods for making molecular containers from simple building blocks. These molecular containers are of great interest as chemists have shown that the hollow cavity within their centre can be used to capture a wide range of guest molecules on the inside the container. Chemists often choose to capture guest molecules with biological relevance as these systems then have the potential to then be used for medical applications; for example to treat diseases within our bodies, e.g. for capturing anticancer drug molecules with long-term potential uses in the treatment of cancer or for the sensing of sugar molecules which holds potential applications in diagnosing and management of diabetes. However, one of the major drawbacks of many existing molecular containers is that because they are made from rigid artificial building blocks, these inflexible molecular containers are unable to display responsive behaviour. As a result, the rigid molecules containers, unlike biological systems, are not able to adapt to the changes in environment and, instead of being able to treat a disease at a specific site within our bodies, they will interact with different molecules within our bodies and lose their ability to effectively treat the disease at its source. Therefore, in order to make full use of the potential of these molecular containers for medical applications within our bodies (for example sugar sensing and anticancer treatments) we need to make sure that they can interact with only the desired guest molecule (be that a sugar or drug molecule) and not with all the other undesired components and molecules within our bodies. The proposed research addresses this problem associated with existing rigid molecular containers and describes the development of a new type of molecular container that uses flexible building blocks made from biologically inspired components. These new molecular containers have specific sites incorporated into their central cavity which allows them to be able to selectively interact with the one desired guest molecule from a large mixture of guest molecules. The ability of these flexible molecular containers to selectively interact with one molecule in a complex mixture of molecules is inspired by the "lock-and-key" mechanisms used by many biological systems. Moreover, the flexible nature of the biologically inspired building blocks also allows these new molecular containers to undergo controlled changes in their shape so that they can completely break apart in order to release the guest molecule from the central cavity in a controlled manner when desired. This responsive behaviour of the molecular container, for the controlled capture and release of one specific and desired guest molecule (for example an anti-cancer drug molecule) even in the presence of large numbers of other undesired guest molecules, means that they have the potential to adapt to the complicated environments found within our bodies. As a result of this responsive behaviour, these new flexible molecular containers have the potential to be used for biomedical applications e.g. capturing an anticancer drug molecule, transporting it to the site of tumour within our bodies and then releasing the anticancer drug at the tumour site in order to treat the disease in a more efficient manner than current anti-cancer treatments. The development of these new molecular containers, which contain flexible biological building blocks, that are able to adapt to interact with one desired guest molecule from a complex mixture, have a clear advantage over many existing ones as they have the striking potential to carry out medical applications within our bodies, for example the sensing of a sugar molecule or deliver an anticancer drug to a tumour site.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Reversible conformational switching of a photo-responsive ortho-azobenzene/2,6-pyridyldicarboxamide heterofoldamer.
光响应性邻偶氮苯/2,6-吡啶二甲酰胺杂折叠体的可逆构象转换。
DOI: 10.1039/d3ob01137b
发表时间: 2023
期刊: Organic & biomolecular chemistry
影响因子: 3.2
作者: [Pike SJ]
通讯作者: Pike SJ
DOI: 10.3389/fchem.2021.709161
发表时间: 2021
期刊: Frontiers in chemistry
影响因子: 5.5
作者: [Delfosse P, Seaton CC, Male L, Lord RM, Pike SJ]
通讯作者: Pike SJ
DOI: 10.1002/chem.202002517
发表时间: 2020-11-20
期刊: Chemistry (Weinheim an der Bergstrasse, Germany)
影响因子: --
作者: [Kergreis A, Lord RM, Pike SJ]
通讯作者: Pike SJ
Adaptive Artificial Receptors for Biomimetic Functions
  • 批准号:
    MR/X023303/1
  • 项目类别:
    Fellowship
  • 资助金额:
    $75.7万
  • 财政年份:
    2024
  • 负责人:
    Sarah Pike
  • 依托单位:
Adaptive Artificial Receptors for Biomimetic Functions
  • 批准号:
    MR/S035486/1
  • 项目类别:
    Fellowship
  • 资助金额:
    $71.78万
  • 财政年份:
    2020
  • 负责人:
    Sarah Pike
  • 依托单位:
海外基金